HRP20030833B1 - Liquid pharmaceutical composition - Google Patents

Liquid pharmaceutical composition

Info

Publication number
HRP20030833B1
HRP20030833B1 HR20030833A HRP20030833A HRP20030833B1 HR P20030833 B1 HRP20030833 B1 HR P20030833B1 HR 20030833 A HR20030833 A HR 20030833A HR P20030833 A HRP20030833 A HR P20030833A HR P20030833 B1 HRP20030833 B1 HR P20030833B1
Authority
HR
Croatia
Prior art keywords
pharmaceutical composition
liquid pharmaceutical
composition
polyhydric alcohols
volume
Prior art date
Application number
HR20030833A
Other languages
English (en)
Croatian (hr)
Inventor
Mahesh Kulkarni Neema
Schneider Michael
Bernard Silbering Steven
Richard Meyer-Wonnay Hans
Sanii-Yahyai Nahid
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26968180&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20030833(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of HRP20030833A2 publication Critical patent/HRP20030833A2/hr
Publication of HRP20030833B1 publication Critical patent/HRP20030833B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
HR20030833A 2001-05-25 2002-04-29 Liquid pharmaceutical composition HRP20030833B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29383201P 2001-05-25 2001-05-25
US34373301P 2001-10-25 2001-10-25
PCT/IB2002/001500 WO2002094220A1 (en) 2001-05-25 2002-04-29 Liquid pharmaceutical composition

Publications (2)

Publication Number Publication Date
HRP20030833A2 HRP20030833A2 (en) 2004-08-31
HRP20030833B1 true HRP20030833B1 (en) 2007-04-30

Family

ID=26968180

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030833A HRP20030833B1 (en) 2001-05-25 2002-04-29 Liquid pharmaceutical composition

Country Status (43)

Country Link
US (2) US20020198261A1 (sr)
EP (1) EP1395242B1 (sr)
JP (1) JP2004534764A (sr)
KR (1) KR100582963B1 (sr)
CN (1) CN100346779C (sr)
AP (1) AP1815A (sr)
AR (1) AR033922A1 (sr)
AT (1) ATE334656T1 (sr)
AU (1) AU2002258026B2 (sr)
BG (1) BG108376A (sr)
BR (1) BR0209973A (sr)
CA (1) CA2446574C (sr)
CR (1) CR7150A (sr)
CY (1) CY1105147T1 (sr)
CZ (1) CZ299755B6 (sr)
DE (1) DE60213592T2 (sr)
DK (1) DK1395242T3 (sr)
DO (1) DOP2002000403A (sr)
EA (1) EA008087B1 (sr)
EE (1) EE200300587A (sr)
EG (1) EG24078A (sr)
ES (1) ES2265040T3 (sr)
GE (1) GEP20053620B (sr)
HR (1) HRP20030833B1 (sr)
HU (1) HUP0401366A2 (sr)
IL (1) IL158359A0 (sr)
IS (1) IS2428B (sr)
MA (1) MA27026A1 (sr)
MX (1) MXPA03009392A (sr)
MY (1) MY128615A (sr)
NO (1) NO20035200D0 (sr)
NZ (1) NZ529173A (sr)
OA (1) OA12604A (sr)
PA (1) PA8545901A1 (sr)
PE (1) PE20030087A1 (sr)
PL (1) PL366384A1 (sr)
PT (1) PT1395242E (sr)
RS (1) RS87203A (sr)
SI (1) SI1395242T1 (sr)
SK (1) SK286227B6 (sr)
SV (1) SV2003001053A (sr)
WO (1) WO2002094220A1 (sr)
ZA (1) ZA200308393B (sr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001876A (en) 1996-07-24 1999-12-14 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
JP2005539092A (ja) * 2002-08-15 2005-12-22 ファイザー・インク 縮合二環式または三環式アミノ酸の治療における使用
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
CN101862317A (zh) * 2002-12-13 2010-10-20 沃尼尔·朗伯有限责任公司 用于治疗纤维肌痛和其它疾病的普加巴林衍生物
DE60315258T2 (de) * 2002-12-20 2008-05-08 Dynogen Pharmaceuticals Inc., Waltham Behandlung von nicht-schmerzhaften blasenstörungen mit modulatoren der alpha-2-delta-untereinheit des calciumkanals
US7169812B2 (en) * 2003-07-01 2007-01-30 Medtronic, Inc. Process for producing injectable gabapentin compositions
DE602004024317D1 (de) * 2003-09-12 2010-01-07 Pfizer Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
US7691880B2 (en) * 2003-10-08 2010-04-06 Mallinckrodt Inc. Methylphenidate solution and associated methods of administration and production
US20050090548A1 (en) * 2003-10-23 2005-04-28 Medtronic, Inc. Intrathecal gabapentin for treatment of epilepsy
US20050090549A1 (en) * 2003-10-23 2005-04-28 Medtronic, Inc. Intrathecal gabapentin for treatment of pain
EP1543831A1 (en) * 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Pregabalin composition
DE102004015752B4 (de) * 2004-03-31 2007-04-05 Christian-Albrechts-Universität Zu Kiel Verwendung von Gabapentin-Laktam zur Behandlung renaler Erkrankungen
AU2005292853C1 (en) * 2004-10-14 2010-08-05 Daikin Industries, Ltd. Atmosphere modifying method and spray agent and spray device used in the same
CA2618474A1 (en) * 2005-08-11 2007-02-15 Boehringer Ingelheim International Gmbh Compounds for treating alzheimer's disease
JP2009504614A (ja) * 2005-08-11 2009-02-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アルツハイマー病の治療用化合物
DE102007019071A1 (de) * 2007-04-23 2008-10-30 Ratiopharm Gmbh Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
SG176464A1 (en) 2008-05-09 2011-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
EP2246044A1 (en) * 2009-04-21 2010-11-03 Pierre Fabre Dermo-Cosmétique Paediatric solutions comprising a beta-blocker
HU230031B1 (hu) 2010-03-01 2015-05-28 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény
TR201005241A1 (tr) * 2010-05-25 2012-01-23 Sanovel �La� San. Ve T�C. A.�. Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
WO2015144825A1 (en) * 2014-03-27 2015-10-01 Sanovel Ilac Sanayi Ve Ticaret A.S. Oral liquid pharmaceutical solution of gabapentin
CN104940930A (zh) * 2015-05-31 2015-09-30 黑龙江佰彤儿童药物研究有限公司 一种治疗儿童癫痫药物口服乳剂及其制备方法
WO2018167628A1 (en) 2017-03-13 2018-09-20 Ftf Pharma Private Limited Pharmaceutical composition of oral suspension of immunosuppressive agents
WO2019038584A1 (en) 2017-08-19 2019-02-28 Ftf Pharma Private Limited An oral pharmaceutical composition comprising zonisamide and process of preparation thereof
WO2019186515A1 (en) * 2018-03-30 2019-10-03 Ftf Pharma Private Limited Liquid pharmaceutical compositions of antiepileptic drugs
WO2020039264A2 (en) * 2018-08-18 2020-02-27 Ftf Pharma Private Limited Chemotherapeutic pharmaceutical suspension for oral dosage
GB2591389A (en) 2018-08-18 2021-07-28 Ftf Pharma Private Ltd Pharmaceuticals solution for oral dosage
EP3836898A2 (en) 2018-08-18 2021-06-23 FTF Pharma Private Limited Pharmaceutical suspension for oral dosage
ES3064256T3 (en) * 2019-03-26 2026-04-23 Orion Corp Pregabalin formulations and use thereof
MX2023008648A (es) 2021-01-22 2023-10-06 Egyt Gyogyszervegyeszeti Gyar Formulacion topica que contiene compuestos fosfolipidicos modificados.
HU231397B1 (hu) 2021-01-22 2023-06-28 Egis Gyógyszergyár Zrt. Pregabalint tartalmazó topikális gyógyszerkészítmény
US20240099989A1 (en) * 2021-02-05 2024-03-28 Kinki University Agent for preventing or improving peripheral neuropathy
CA3230309A1 (en) * 2021-08-31 2023-03-09 Jr. Samuel A. Testino Stable gabapentin powder
WO2024058812A1 (en) 2022-09-16 2024-03-21 Pyros Pharmaceuticals, Inc. Vigabatrin liquid pharmaceutical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
IL139298A0 (en) * 1998-05-15 2001-11-25 Warner Lambert Co Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
IL155704A0 (en) * 2000-11-30 2003-11-23 Pfizer Prod Inc Combination of gaba agonists and sorbitol dehydrogenase inhibitors

Also Published As

Publication number Publication date
EA200301152A1 (ru) 2004-04-29
US20040072904A1 (en) 2004-04-15
IS2428B (is) 2008-10-15
HUP0401366A2 (hu) 2004-11-29
NO20035200L (no) 2003-11-24
SV2003001053A (es) 2003-03-18
EE200300587A (et) 2004-02-16
JP2004534764A (ja) 2004-11-18
EP1395242B1 (en) 2006-08-02
RS87203A (sr) 2006-10-27
GEP20053620B (en) 2005-09-26
BG108376A (bg) 2005-04-30
CR7150A (es) 2004-02-23
CN1509165A (zh) 2004-06-30
DK1395242T3 (da) 2006-10-30
CY1105147T1 (el) 2010-03-03
IS6986A (is) 2003-10-09
AP2003002907A0 (en) 2003-12-31
MA27026A1 (fr) 2004-12-20
BR0209973A (pt) 2004-04-06
OA12604A (en) 2006-06-08
MXPA03009392A (es) 2004-01-29
PT1395242E (pt) 2006-11-30
ATE334656T1 (de) 2006-08-15
US7256216B2 (en) 2007-08-14
KR100582963B1 (ko) 2006-05-24
US20020198261A1 (en) 2002-12-26
CA2446574A1 (en) 2002-11-28
NO20035200D0 (no) 2003-11-24
HRP20030833A2 (en) 2004-08-31
CZ299755B6 (cs) 2008-11-12
ES2265040T3 (es) 2007-02-01
EP1395242A1 (en) 2004-03-10
KR20040003006A (ko) 2004-01-07
HK1062646A1 (zh) 2004-11-19
DE60213592D1 (de) 2006-09-14
EA008087B1 (ru) 2007-02-27
EG24078A (en) 2008-05-11
NZ529173A (en) 2005-07-29
CZ20033066A3 (cs) 2004-08-18
PE20030087A1 (es) 2003-02-14
PL366384A1 (en) 2005-01-24
WO2002094220A1 (en) 2002-11-28
DE60213592T2 (de) 2007-08-09
AU2002258026B2 (en) 2007-08-02
MY128615A (en) 2007-02-28
AR033922A1 (es) 2004-01-07
SK286227B6 (sk) 2008-05-06
ZA200308393B (en) 2005-04-26
CA2446574C (en) 2008-04-01
DOP2002000403A (es) 2002-11-30
SK14112003A3 (sk) 2004-08-03
SI1395242T1 (en) 2006-10-31
IL158359A0 (en) 2004-05-12
AP1815A (en) 2008-01-04
PA8545901A1 (es) 2003-09-05
CN100346779C (zh) 2007-11-07

Similar Documents

Publication Publication Date Title
EP1649760A4 (en) COMPOSITION CONTAINING EQUOLPRODUCATING MILKY ACID BACTERIA
EP0732930A4 (en) Compositions that inhibit apoptosis, method of cleaning the compositions and their use
HN2002000154A (es) Azaindoles
ATE409512T1 (de) Verbindungen zur kontrollierten freigabe aktiver molekülen
DK1273299T3 (da) Minoxidilinindeholdende praparater
MEP90508A (en) New pharmaceutical composition
MX2009002220A (es) Sistemas y metodos desinfectantes.
UY27329A1 (es) Champues con alcohol de behenilo
CR8107A (es) Fungicida
ES2193874B1 (es) Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas.
MY126917A (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
HRP20070577T4 (hr) Derivati kinazolinona koji se mogu upotrijebiti kao antagonisti vaniloida
DE602004005890D1 (de) Moschus-geruchsstoffe
DE60311830D1 (de) Wasserlöslicher behälter
BR0300709A (pt) Sal de perindopril e as composições farmacêuticas contendo o mesmo
DE60132441D1 (de) A als inhibitor der no-synthase und verwendungen
PL1553162T3 (pl) Toaletowe kostki
TNSN98013A1 (fr) Derives de 5 - aroylnaphtalene a action anti-inflammatoire et analgesique, compositions pharmaceutiques les contenant, et procedes pour les utiliser et les preparer.
ATE342880T1 (de) Aliphatische verbindungen als duftstoffe mit moschuscharakter
CO5590936A2 (es) Compuesto farmaceutico que contiene sfcyr iib o sfcyr iii
EP1148783A4 (en) CONVERSION OF COX INHIBITING, NON COX-2 SELECTIVE INHIBITORS TO DERIVATIVES OF COX-2 SELECTIVE INHIBITORS
DE60001366D1 (de) Orale zusammensetzung enthaltend perlit
DE602004029459D1 (de) Verbessertes reinigungsmittel
DK1212072T3 (da) Farmaceutisk præparat omfattende eukalyptus- og orangeolie
ATE255407T1 (de) Pharmazeutische zusammensetzungen, die terbinafin enthalten

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20080402

Year of fee payment: 7

PBON Lapse due to non-payment of renewal fee

Effective date: 20090430